Comparative studies of the proteome, glycoproteome, and N-glycome of clear cell renal cell carcinoma plasma before and after curative nephrectomy

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 4889-4900

  Gbormittah, Francisca O ^a   Lee, Ling Y ^b   Taylor, Kyonese ^a   Hancock, William S ^a   Iliopoulos, Othon ^c,d  

^a NORTHEASTERN UNIVERSITY   (United States)

^b MACQUARIE UNIVERSITY   (Australia)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

glycomics; Glycoproteomics; lectins; multi lectin affinity chromatography; N glycans

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN; APOLIPOPROTEIN F; APOLIPOPROTEIN L1; ATTRACTIN; BLOOD CLOTTING FACTOR 11; CHOLESTEROL ESTER TRANSFER PROTEIN; COMPLEMENT COMPONENT C4B; DESMOPLAKIN; GLUTATHIONE PEROXIDASE 3; GLYCAN; GLYCOPROTEIN; GLYCOPROTEOME; HISTONE H4; JUNCTION PLAKOGLOBIN; L SELECTIN; LEUKOAGGLUTININ; N ACETYLMURAMOYLALANINE AMIDASE; N GLYCAN; N GLYCOME; PHOSPHOLIPID TRANSFER PROTEIN; PLAKOGLOBIN; PROTEIN CD146; PROTEIN ECM1; PROTEIN HSPG2; PROTEIN SELL; PROTEIN SYNE1; PROTEIN VCAM1; PROTEOME; SEX HORMONE BINDING GLOBULIN; UNCLASSIFIED DRUG; POLYSACCHARIDE; TUMOR MARKER;

ALEURIA AURANTIA; ARTICLE; BREAST CARCINOMA; CANCER SURGERY; CARCINOGENESIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CURATIVE NEPHRECTOMY; HUMAN; KIDNEY CARCINOMA; LIQUID CHROMATOGRAPHY; MEDICINAL PLANT; NEPHRECTOMY; PHASEOLUS VULGARIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEOMICS; SAMBUCUS NIGRA; TANDEM MASS SPECTROMETRY; UPREGULATION; BLOOD; CARCINOMA, RENAL CELL; CELL FRACTIONATION; METABOLISM; POSTOPERATIVE PERIOD; PROCEDURES;

BIOMARKERS, TUMOR; CARCINOMA, RENAL CELL; CELL FRACTIONATION; CHROMATOGRAPHY, LIQUID; GLYCOPROTEINS; HUMANS; NEPHRECTOMY; POLYSACCHARIDES; POSTOPERATIVE PERIOD; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84908887664     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500591e     Document Type: Article

References (57)

1. Linehan, W. M.; Walther, M. M.; Zbar, B. The genetic basis of cancer of the kidney J. Urol. 2003, 170, 2163-72
2. Pantuck, A. J.; Zisman, A.; Belldegrun, A. S. The changing natural history of renal cell carcinoma J. Urol. 2001, 166, 1611-23
3. Weiss, R. H.; Lin, P. Y. Kidney cancer: identification of novel targets for therapy Kidney Int. 2006, 69, 224-32
4. Herrmann, W.; Stockle, M.; Sand-Hill, M.; Hubner, U.; Herrmann, M.; Obeid, R.; Wullich, B.; Loch, T.; Geisel, J. The measurement of complexed prostate-specific antigen has a better performance than total prostate-specific antigen Clin. Chem. Lab. Med. 2004, 42, 1051-7
5. Yang, Z.; Hancock, W. S. Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column J. Chromatogr. A 2004, 1053, 79-88
6. Chen, S.; LaRoche, T.; Hamelinck, D.; Bergsma, D.; Brenner, D.; Simeone, D.; Brand, R. E.; Haab, B. B. Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays Nat. Methods 2007, 4, 437-44
7. Teng, P. N.; Hood, B. L.; Sun, M.; Dhir, R.; Conrads, T. P. Differential proteomic analysis of renal cell carcinoma tissue interstitial fluid J. Proteome Res. 2011, 10, 1333-42
8. Zeng, Z.; Hincapie, M.; Pitteri, S. J.; Hanash, S.; Schalkwijk, J.; Hogan, J. M.; Wang, H.; Hancock, W. S. A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome Anal. Chem. 2011, 83, 4845-54
9. Plavina, T.; Wakshull, E.; Hancock, W. S.; Hincapie, M. Combination of abundant protein depletion and multi-lectin affinity chromatography (M-LAC) for plasma protein biomarker discovery J. Proteome Res. 2007, 6, 662-71
10. Abbott, K. L.; Aoki, K.; Lim, J. M.; Porterfield, M.; Johnson, R.; ORegan, R. M.; Wells, L.; Tiemeyer, M.; Pierce, M. Targeted glycoproteomic identification of biomarkers for human breast carcinoma J. Proteome Res. 2008, 7, 1470-80
11. Gao, Y.; Ma, F.; Zhang, W.; Zhong, F.; Tang, H.; Xu, D.; Zhao, L. O-Glycan profiling of serum glycan for potential renal cancer biomarkers Sci. China: Life Sci. 2013, 56, 739-44
12. Kullolli, M.; Hancock, W. S.; Hincapie, M. Automated platform for fractionation of human plasma glycoproteome in clinical proteomics Anal. Chem. 2010, 82, 115-20
13. Matsumura, K.; Higashida, K.; Ishida, H.; Hata, Y.; Yamamoto, K.; Shigeta, M.; Mizuno-Horikawa, Y.; Wang, X.; Miyoshi, E.; Gu, J.; Taniguchi, N. Carbohydrate binding specificity of a fucose-specific lectin from Aspergillus oryzae: a novel probe for core fucose J. Biol. Chem. 2007, 282, 15700-8
14. Fischer, E.; Brossmer, R. Sialic acid-binding lectins: submolecular specificity and interaction with sialoglycoproteins and tumour cells Glycoconjugate J. 1995, 12, 707-13
15. Li, W. P.; Zuber, C.; Roth, J. Use of Phaseolus vulgaris leukoagglutinating lectin in histochemical and blotting techniques: a comparison of digoxigenin-and biotin-labelled lectins Histochemistry 1993, 100, 347-56
16. DallOlio, F.; Chiricolo, M. Sialyltransferases in cancer Glycoconjugate J. 2001, 18, 841-50
17. Pousset, D.; Piller, V.; Bureaud, N.; Monsigny, M.; Piller, F. Increased α2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma Cancer Res. 1997, 57, 4249-56
18. Recchi, M. A.; Hebbar, M.; Hornez, L.; Harduin-Lepers, A.; Peyrat, J. P.; Delannoy, P. Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer Cancer Res. 1998, 58, 4066-70
19. Takada, A.; Ohmori, K.; Yoneda, T.; Tsuyuoka, K.; Hasegawa, A.; Kiso, M.; Kannagi, R. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium Cancer Res. 1993, 53, 354-61
20. Dube, D. H.; Bertozzi, C. R. Glycans in cancer and inflammation-potential for therapeutics and diagnostics Nat. Rev. Drug Discovery 2005, 4, 477-88
21. Turner, G. A.; Skillen, A. W.; Buamah, P.; Guthrie, D.; Welsh, J.; Harrison, J.; Kowalski, A. Relation between raised concentrations of fucose, sialic acid, and acute phase proteins in serum from patients with cancer: choosing suitable serum glycoprotein markers J. Clin. Pathol. 1985, 38, 588-92
22. Jensen, P. H.; Karlsson, N. G.; Kolarich, D.; Packer, N. H. Structural analysis of N-and O-glycans released from glycoproteins Nat. Protoc. 2012, 7, 1299-310
23. Gbormittah, F. O.; Haab, B. B.; Partyka, K.; Garcia-Ott, C.; Hancapie, M.; Hancock, W. S. Characterization of glycoproteins in pancreatic cyst fluid using a high-performance multiple lectin affinity chromatography platform J. Proteome Res. 2014, 13, 289-99
24. Leymarie Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012 Mol. Cell. Proteomics 2013, 12, 2935-2951
25. 2+-binding proteins and their peptides in psoriasis patients Clin. Chem. 2008, 54, 1805-14
26. Yang, Z.; Harris, L. E.; Palmer-Toy, D. E.; Hancock, W. S. Multilectin affinity chromatography for characterization of multiple glycoprotein biomarker candidates in serum from breast cancer patients Clin. Chem. 2006, 52, 1897-905
27. Abbott, K. L.; Lim, J. M.; Wells, L.; Benigno, B. B.; McDonald, J. F.; Pierce, M. Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis Proteomics 2010, 10, 470-81
28. Batruch, I.; Lecker, I.; Kagedan, D.; Smith, C. R.; Mullen, B. J.; Grober, E.; Lo, K. C.; Diamandis, E. P.; Jarvi, K. A. Proteomic analysis of seminal plasma from normal volunteers and post-vasectomy patients identifies over 2000 proteins and candidate biomarkers of the urogenital system J. Proteome Res. 2011, 10, 941-53
29. Bones, J.; Byrne, J. C.; ODonoghue, N.; McManus, C.; Scaife, C.; Boissin, H.; Nastase, A.; Rudd, P. M. Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms J. Proteome Res. 2011, 10, 1246-65
30. Zheng, X.; Wu, S. L.; Hincapie, M.; Hancock, W. S. Study of the human plasma proteome of rheumatoid arthritis J. Chromatogr. A 2009, 1216, 3538-45
31. Feng, G.; Fang, F.; Liu, C.; Zhang, F.; Huang, H.; Pu, C. CD146 gene expression in clear cell renal cell carcinoma: a potential marker for prediction of early recurrence after nephrectomy Int. Urol. Nephrol. 2012, 44, 1663-9
32. Wu, G. J.; Wu, M. W.; Wang, S. W.; Liu, Z.; Qu, P.; Peng, Q.; Yang, H.; Varma, V. A.; Sun, Q. C.; Petros, J. A.; Lim, S. D.; Amin, M. B. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression Gene 2001, 279, 17-31
33. Wu, Z.; Li, J.; Yang, X.; Wang, Y.; Yu, Y.; Ye, J.; Xu, C.; Qin, W.; Zhang, Z. MCAM is a novel metastasis marker and regulates spreading, apoptosis and invasion of ovarian cancer cells Tumor Biol. 2012, 33, 1619-28
34. Imbert, A. M.; Garulli, C.; Choquet, E.; Koubi, M.; Aurrand-Lions, M.; Chabannon, C. CD146 expression in human breast cancer cell lines induces phenotypic and functional changes observed in epithelial to mesenchymal transition PLoS One 2012, 7, e43752
35. Schon, M.; Kahne, T.; Gollnick, H.; Schon, M. P. Expression of gp130 in tumors and inflammatory disorders of the skin: formal proof of its identity as CD146 (MUC18, Mel-CAM) J. Invest. Dermatol. 2005, 125, 353-63
36. Kristiansen, G.; Yu, Y.; Schluns, K.; Sers, C.; Dietel, M.; Petersen, I. Expression of the cell adhesion molecule CD146/MCAM in non-small cell lung cancer Anal. Cell. Pathol. 2003, 25, 77-81
37. Malyszko, J.; Malyszko, J. S.; Brzosko, S.; Wolczynski, S.; Mysliwiec, M. Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients J. Clin. Endocrinol. Metab. 2004, 89, 4620-7
38. Yang, Z.; Hancock, W. S. Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column J. Chromatogr. A 2004, 1053, 79-88
39. Pawlik, T. M.; Hawke, D. H.; Liu, Y.; Krishnamurthy, S.; Fritsche, H.; Hunt, K. K.; Kuerer, H. M. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein BMC Cancer 2006, 6, 68
40. Woltje, M.; Tschoke, B.; von Bulow, V.; Westenfeld, R.; Denecke, B.; Graber, S.; Jahnen-Dechent, W. CCAAT enhancer binding protein beta and hepatocyte nuclear factor 3beta are necessary and sufficient to mediate dexamethasone-induced up-regulation of alpha2HS-glycoprotein/fetuin-A gene expression J. Mol. Endocrinol. 2006, 36, 261-77
41. Andersen, C. L.; Schepeler, T.; Thorsen, K.; Birkenkamp-Demtroder, K.; Mansilla, F.; Aaltonen, L. A.; Laurberg, S.; Orntoft, T. F. Clusterin expression in normal mucosa and colorectal cancer Mol. Cell. Proteomics 2007, 6, 1039-48
42. Tousi, F.; Bones, J.; Iliopoulos, O.; Hancock, W. S.; Hincapie, M. Multidimensional liquid chromatography platform for profiling alterations of clusterin N-glycosylation in the plasma of patients with renal cell carcinoma J. Chromatogr. A 2012, 1256, 121-8
43. Yamamoto, N.; Naraparaju, V. R.; Asbell, S. O. Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients Cancer Res. 1996, 56, 2827-31
44. Yamamoto, N.; Naraparaju, V. R.; Urade, M. Prognostic utility of serum alpha-N-acetylgalactosaminidase and immunosuppression resulted from deglycosylation of serum Gc protein in oral cancer patients Cancer Res. 1997, 57, 295-9
45. Yamamoto, N.; Suyama, H.; Ushijima, N. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF) Int. J. Cancer 2008, 122, 461-7
46. Rehder, D. S.; Nelson, R. W.; Borges, C. R. Glycosylation status of vitamin D binding protein in cancer patients Protein Sci. 2009, 18, 2036-42
47. Everest-Dass, A. V.; Jin, D.; Thaysen-Andersen, M.; Nevalainen, H.; Kolarich, D.; Packer, N. H. Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans Glycobiology 2012, 22, 1465-79
48. Nakano, M.; Saldanha, R.; Gobel, A.; Kavallaris, M.; Packer, N. H. Identification of glycan structure alterations on cell membrane proteins in desoxyepothilone B resistant leukemia cells Mol. Cell. Proteomics 2011, 10, M111.009001
49. Borzym-Kluczyk, M.; Radziejewska, I.; Darewicz, B. Glycosylation of proteins in healthy and pathological human renal tissues Folia Histochem. Cytobiol. 2012, 50, 599-604
50. Dallolio, F. Protein glycosylation in cancer biology: an overview Clin. Mol. Pathol. 1996, 49, M126-35
51. Kim, Y. J.; Varki, A. Perspectives on the significance of altered glycosylation of glycoproteins in cancer Glycoconjugate J. 1997, 14, 569-76
52. Yoshimura, M.; Nishikawa, A.; Ihara, Y.; Taniguchi, S.; Taniguchi, N. Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 8754-8
53. Gessner, P.; Riedl, S.; Quentmaier, A.; Kemmner, W. Enhanced activity of CMP-neuAc:Galβ1-4GlcNAc:α2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients Cancer Lett. 1993, 75, 143-9
54. Kannagi, R. Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited Glycoconjugate J. 2004, 20, 353-64
55. Lin, S.; Kemmner, W.; Grigull, S.; Schlag, P. M. Cell surface α2,6 sialylation affects adhesion of breast carcinoma cells Exp. Cell Res. 2002, 276, 101-10
56. de Leoz, M. L.; Young, L. J.; An, H. J.; Kronewitter, S. R.; Kim, J.; Miyamoto, S.; Borowsky, A. D.; Chew, H. K.; Lebrilla, C. B. High-mannose glycans are elevated during breast cancer progression Mol. Cell. Proteomics 2011, 10, M110.002717
57. Lattova, E.; Varma, S.; Bezabeh, T.; Petrus, L.; Perreault, H. Mass spectrometric profiling of N-linked oligosaccharides and uncommon glycoform in mouse serum with head and neck tumor J. Am. Soc. Mass Spectrom. 2008, 19, 671-85